Veritas In Silico (TSE:130A) Pretax Margin %: % (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
11 GF Score
Price 円418.00
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico Pretax Margin %?

Veritas In Silico TSE:130A -3.91% 11 Pretax Margin % is % as of Dec. 2025. GuruFocus rates TSE:130A with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 942 Biotechnology companies, Veritas In Silico ranks worse than 78.24% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Veritas In Silico's Pre-Tax Income for the three months ended in Dec. 2025 was 円0.00 Mil. Veritas In Silico's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, Veritas In Silico's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Veritas In Silico's Pretax Margin % or its related term are showing as below:

TSE:130A' s Pretax Margin % Range Over the Past 10 Years
Min: -968.34   Med: -120   Max: 9.96
Current: -968.34

TSE:130A's Pretax Margin % is ranked worse than
78.24% of 942 companies
in the Biotechnology industry
Industry Median: -89.895 vs TSE:130A: -968.34

Veritas In Silico  (TSE:130A) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Veritas In Silico Pretax Margin % Related Terms

Veritas In Silico Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Veritas In Silico's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico Pretax Margin % Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
-386.77 -77.48 9.96 -120.00 -462.96

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -328.33 -537.11 0.00 0.00 -1,435.90

TSE:130A vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Veritas In Silico's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Pretax Margin % falls into.


TSE:130A
11GF Score
Veritas In Silico Inc TSE:130A
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veritas In Silico Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Veritas In Silico's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-421.946/91.14
=-462.96 %

Veritas In Silico's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Veritas In Silico (TSE:130A) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Veritas In Silico and its competitors. According to the industry distribution chart, Veritas In Silico ranks #737 out of 942 companies in the Biotechnology industry, placing it in the top 78.2%.
Is Veritas In Silico's Pretax Margin % too high?
Veritas In Silico's current Pretax Margin % is %. Based on the distribution chart, Veritas In Silico ranks #737 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Veritas In Silico has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Veritas In Silico's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Veritas In Silico ranks #737 out of 942 companies for Pretax Margin %. This places Veritas In Silico in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Veritas In Silico and its competitors. Veritas In Silico's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veritas In Silico stock overvalued right now?
Veritas In Silico (TSE:130A) has a current Pretax Margin % of %. The current Pretax Margin % is %. Veritas In Silico's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Veritas In Silico (TSE:130A), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
11GF Score

Get the complete analysis for TSE:130A

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円418.00
Price